Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Behav Neurosci. 2011 Jun;125(3):473–479. doi: 10.1037/a0023561

Discrimination Learning and Attentional Set Formation in a Mouse Model of Fragile X

Kimberly S Casten 2, Annette C Gray 2, Rebecca D Burwell 1,2
PMCID: PMC3109093  NIHMSID: NIHMS288787  PMID: 21517146

Abstract

Fragile X Syndrome is the most prevalent genetic cause of mental retardation. Selective deficits in executive function, including inhibitory control and attention, are core features of the disorder. In humans, Fragile X results from a trinucleotide repeat in the Fmr1 gene that renders it functionally silent and has been modeled in mice by targeted deletion of the Fmr1 gene. Fmr1 knockout (KO) mice recapitulate many features of Fragile X syndrome, but evidence for deficits in executive function is inconsistent. To address this issue, we trained wild-type and Fmr1 KO mice on an experimental paradigm that assesses attentional set-shifting. Mice learned to discriminate between stimuli differing in two of three perceptual dimensions. Successful discrimination required attending only to the relevant dimension, while ignoring irrelevant dimensions. Mice were trained on three discriminations in the same perceptual dimension, each followed by a reversal. This procedure normally results in the formation of an attentional set to the relevant dimension. Mice were then required to shift attention and discriminate based on a previously irrelevant perceptual dimension. Wild-type mice exhibited the increase in trials to criterion expected when shifting attention from one perceptual dimension to another. In contrast, the Fmr1 KO group failed to show the expected increase, suggesting impairment in forming an attentional set. Fmr1 KO mice also exhibited a general impairment in learning discriminations and reversals. This is the first demonstration that Fmr1 KO mice show a deficit in attentional set formation.

Keywords: prefrontal, cognition, transgenic mice, behavior


Fragile X Syndrome (FXS) is the most common known genetic cause of intellectual disability, affecting an estimated 1:4000 males and 1:8000 females (Turner, Webb, Wake, & Robinson, 1996). FXS patients suffer from dysmorphic facial features, macroorchidism, increased susceptibility to epilepsy, a general learning impairment, and specific cognitive-behavioral deficits distinct from other learning disabilities. Boys with FXS tend to be hyperactive; impulsive; resistant to change in stimuli, conditions, or environment; and hypersensitive and hyper-reactive to stimuli (Freund & Reiss, 1991; Hagerman, Amiri, & Cronister, 1991; Kau, Reider, Payne, Meyer, & Freund, 2000; Levitas, 1996; Reiss & Freund, 1990). They also commonly exhibit impairments in social cognition and attention (K. Cornish et al., 2005; K. Cornish, Scerif, & Karmiloff-Smith, 2007; K. Cornish, Sudhalter, & Turk, 2004; K. M. Cornish, Munir, & Cross, 2001; Hooper et al., 2008; Scerif, Cornish, Wilding, Driver, & Karmiloff-Smith, 2007). In most cases of FXS, the Fmr1 gene contains an expansion of trinucleotide (CGG) repeats in its 5′ untranslated region that leads to hypermethylation of the Fmr1 promoter, blocking expression of the fragile X mental retardation protein (FMRP) (Devys, Lutz, Rouyer, Bellocq, & Mandel, 1993; Pieretti et al., 1991; Verheij et al., 1993), which is expressed at high levels throughout the developing brain (Abitbol et al., 1993; Hinds et al., 1993). Studies of FXS patients have shown modest enlargement of the hippocampus, caudate nucleus, and fusiform gyrus and decreased volume of the superior temporal gyrus, amygdala, and cerebellar vermis (Gothelf et al., 2008; Hessl, Rivera, & Reiss, 2004; Reiss, Abrams, Greenlaw, Freund, & Denckla, 1995; Reiss, Aylward, Freund, Joshi, & Bryan, 1991). White matter, particularly in frontostriatal pathways, may also be abnormal in FXS patients (Haas et al., 2009; Hoeft et al., 2010; Hoeft et al., 2008). The degree of anatomical abnormality of the caudate and cerebellum may correlate with the degree of intellectual disability (Gothelf, et al., 2008; Mostofsky et al., 1998; Reiss, et al., 1995), highlighting the importance of these structures in cognition and the specific deficits found in FXS.

FXS is associated with selective deficits in executive function, including impaired inhibitory control, working memory, attention, and planning, that become more pronounced as cognitive demands increase (Hooper, et al., 2008; Lanfranchi, Cornoldi, Drigo, & Vianello, 2009; Munir, Cornish, & Wilding, 2000a, 2000b; Ornstein et al., 2008; Scerif, et al., 2007; Wilding, Cornish, & Munir, 2002). Brain regions affected in FXS include those implicated in executive function, including prefrontal areas (Lie, Specht, Marshall, & Fink, 2006; Monchi, Petrides, Petre, Worsley, & Dagher, 2001). Moreover, functional MRI investigations show that FXS patients fail to recruit additional resources in these areas as working memory and inhibitory control tasks become more difficult (Hoeft et al., 2007; Kwon et al., 2001; Lightbody & Reiss, 2009; Menon, Kwon, Eliez, Taylor, & Reiss, 2000; Menon, Leroux, White, & Reiss, 2004; Rivera, Menon, White, Glaser, & Reiss, 2002; Tamm, Menon, Johnston, Hessl, & Reiss, 2002). FXS individuals are also known to have deficits in attentional set shifting (Hooper, et al., 2008), which depends on prefrontal dopamine (Robbins & Arnsten, 2009).

The present study was designed to further examine deficits in executive function in the mouse model of FXS, Fmr1 knockout (KO) mice (Consortium, 1994). The Fmr1 KO mouse expresses a number of endophenotypic markers similar to core defects found in FXS, including macroorchidism, increased susceptibility to epileptic seizures, hyperactivity, increased sensitivity to sensory stimuli, and deficits in learning and memory (Chen & Toth, 2001; Consortium, 1994; Kooy, 2003; Qin, Kang, & Smith, 2002; Zhao et al., 2005). As in humans with FXS, neurons in Fmr1 KO mice have immature dendritic spines and an increased density of spines (Comery et al., 1997; Irwin et al., 2001; McKinney, Grossman, Elisseou, & Greenough, 2005; Nimchinsky, Oberlander, & Svoboda, 2001). Fmr1 KO mice show subtle deficits in spatial learning and reversal learning (Consortium, 1994; D'Hooge et al., 1997; Paradee et al., 1999) and display impaired inhibitory control and attention in a five-choice serial reaction time task (Moon et al., 2006), suggesting that the model is useful for studying deficits in executive function. FXS patients have difficulty with the Wisconsin Card Sort Task (WCST) and other tasks that require inhibition of a previously learned rule or target and a shift in attention to a new rule or target (K. M. Cornish, et al., 2001; Hooper, et al., 2008; Mostofsky, et al., 1998). Thus, we hypothesized that Fmr1 KO mice would show similar deficits on a task that requires attentional set shifting.

In this study, we used an attentional set-shifting task originally developed for rats (Birrell & Brown, 2000). Subjects learned discriminations between two stimuli that differed in two of three perceptual dimensions (texture, odor, and digging medium). Only one dimension predicted the location of a food reward. Thus, subjects were required to attend to one perceptual dimension to select the appropriate target and obtain a food reward. Subsequently, subjects were trained to shift attention to novel targets within the same perceptual dimension (intra-dimensional shift, IDS) or to targets within a previously irrelevant dimension (extra-dimensional shift, EDS). In general, IDSs are easier than EDSs. The cost in performance for EDSs is commonly used as an indicator of the formation of an attentional set. Previous studies have failed to demonstrate a difference between IDS and EDS performance in mice (Brigman, Bussey, Saksida, & Rothblat, 2005; Colacicco, Welzl, Lipp, & Wurbel, 2002). To facilitate formation of an attentional set in our paradigm, mice were trained on multiple IDS problems followed by reversals before presentation of the EDS. As predicted, wild-type mice exhibited the expected shift effect, demonstrating that mice can form an attentional set to a perceptual dimension. Importantly, Fmr1 KO mice did not show evidence of attentional set formation. This is the first demonstration of an attentional set-shifting deficit in Fmr1 KO mice.

Methods

Subjects

All subjects were bred in the Brown University Animal Care Facility and kept on a 12:12 hour light:dark cycle. Subjects were 6-7 week-old male F1 generation wild-type (WT; n=9) and Fmr1 KO mice (n=7) bred from male 129P3/J mice and female C57BL/6J mice heterozygous for Fmr1, obtained from Jackson Laboratories (Bar Harbor, ME). Pilot studies indicated that the behavior of interest was most robust in the F1 hybrid. In addition, it has been suggested that behavioral phenotypes of different hybrid crosses should be more alike than phenotypes of different inbred strains (Silva et al., 1997). Genotyping was carried out using PCR on tail DNA extracts. One week before habituation, mice were put on feeding schedules and received 2.9-3.1 grams of LabDiet 5008 Formulab (PMI Nutrition International, LLC, St. Louis, MO) each day. Meals were adjusted to maintain weights at 85-90% ad lib feeding weights. All methods involving the use of live animals conformed to NIH guidelines and were approved by the Brown University Institutional Animal Care and Use Committee.

Apparatus and experimental stimuli

Training and testing sessions were completed in a black plexiglas box (51.5L × 27W × 18H cm), open on the top. For all sessions, two small clay flower pots, (4.3 cm in diameter, 3.7 cm in height) were placed side by side at one end of the apparatus. Food rewards were hidden in one of the two containers presented simultaneously, which could be distinguished by odor, outside texture, and digging medium. The food reward, an ice cream sprinkle (Betty Crocker Carousel Mix), was buried underneath the digging medium. The bottom of each pot was filled with melted wax, which was allowed to harden, to weight the containers for greater stability. When odor stimuli were required, the wax was scented. Habituation pots contained unscented wax, bedding was the digging medium, and there was no added outside texture. Exemplar pots represented only one of the three perceptual dimensions.Testing pots represented all three dimensions: the bottom half of the pot was filled with scented wax; the top half of the pot was filled with one type of digging medium; and a texture stimulus covered the outer surface, including the lip. Pilot studies revealed that covering the outer surface with textured material was insufficient for learning, and extending the texture over the lip of the cup was necessary.

Behavioral training and testing

Each animal completed preliminary training that included habituation, exemplar discrimination, single discrimination (SD), compound discrimination (CD), and reversal. Subsequent testing consisted of three IDSs, each followed by a reversal, an EDS, and a final reversal. Mice were allowed to correct mistakes during the first four trials, after which they were allowed to dig in only one pot. Criterion for advancing to the next phase of the task was eight correct out of 10 consecutive trials. During each phase of testing, one probe trial was given in which the stimuli were presented without a food reward to rule out the possibility that animals used smell of the reward to perform the task. If the mouse chose the correct pot, the experimenter dropped the food reward on the top of the digging medium.

Habituation

Habituation sessions lasted ten minutes, and the position of the containers alternated from one end of the apparatus to the other for each presentation. Mice were trained to consistently dig through the bedding material to the bottom of the containers for food rewards.

Exemplar discrimination

Animals were required to discriminate between successive pairs of exemplar containers that presented and differed in only one of the three perceptual dimensions. One member of the exemplar pair contained the food reward. Mice were exposed to exemplars for each of the three stimulus dimensions: textures were plain or shiny ribbon; odors were juicy melon or cherry blossom; and digging media were dark or light colored tissue paper. Testing stimuli for subsequent phases of the task are presented in Table 1. Order of presentation of perceptual dimensions and the rewarded stimulus were counterbalanced across groups.

Table 1. Stimulus materials for each phase of training and testing.
Phase Texture Medium Odor Example Order of Testing
SD/CD/RV thick yarn
thin yarn
large beads
small beads
black cherry
lavender
thick/ large or small beads/ cherry
thin/ large or small beads/ cherry
IDS1/RV1 flat cord
round cord
round beads
triangular beads
strawberry
ocean mist
flat / round or triangular/ strawberry
round/ round or triangular/ strawberry
IDS2/RV2 plain pipe cleaner
metallic pipe cleaners
small fuzzy balls
large fuzzy balls
pumpkin spice
rose petals
plain/ small or large fuzzy/ pumpkin
metallic/ small or large fuzzy/ pumpkin
IDS3/RV3 cork texture paper
raised dotted paper
large felt squares
small felt squares
woodlands
pralines&cream
cork/ large or small felt/ woodland
raised/ large or small felt/ woodland
EDS/RV4 smooth paper
textured paper
plain paper
shiny paper
mango
vanilla
smooth or textured/ plain/ mango
smooth or textured/ shiny/ mango

Stimulus materials are shown for training which included a simple discrimination (SD), a compound discrimination (CD), and the initial reversal (RV) and for testing which included three intradimensional shifts (IDS) and an extradimensional shift (EDS) each followed by a reversal. Only the stimuli in bold were presented for the SD. In the right column are representative example stimuli. The relevant dimension is shown in bold type, the irrelevant in italics, and the unvarying in regular type. Rewarded stimuli and order of dimensions presented were counterbalanced.

Simple and compound discriminations

After reaching criterion on the exemplar discriminations, animals began SD. Animals were presented with stimulus containers that represented all three perceptual dimensions, but differed on only one of the dimensions. For example, the rewarded container would have Texture 1, Medium 1, and Odor 1, whereas the unrewarded container would exhibit Texture 2, Medium 1, and Odor 1 (Table 1, right column). After reaching criterion on SD, mice began CD, during which the same stimulus dimensions were presented, but the containers now varied in two dimensions. The previously relevant dimension remained relevant, and the second varying dimension did not predict the location of the reward. The third dimension did not vary. For example, the rewarded container would have Texture 1, Medium 1 or 2, and Odor 1, whereas the unrewarded container would exhibit Texture 2, Medium 1 or 2, and Odor1. After reaching criterion on the CD, the animals were presented with a reversal in which the previously unrewarded stimulus was rewarded.

IDS and reversals

After reaching criterion on the SD, CD, and reversal, animals were tested on three intra-dimensional shift (IDS) problems, in which the same two perceptual dimensions varied, the relevant dimension was the same, but a novel set of stimuli were presented. For example, the rewarded container would exhibit Texture 3, Medium 3 or 4, and Odor 3, whereas the unrewarded container would exhibit Texture 4, Medium 3 or 4, and Odor 3 (Table 1, right column). A reversal was performed after animals reached criterion (REV1). Mice were tested on two more IDS problems and reversals.

EDS

After reaching criterion on three subsequent IDSs and reversals, animals were then presented with an EDS, in which novel stimuli were presented and the previously irrelevant, varying dimensions became the relevant dimension. For example, the rewarded container would exhibit Texture 5 or 6, Medium 5, and Odor 5, whereas the unrewarded container would exhibit Texture 5 or 6, Medium 6, and Odor 5 (Table 1, right column). It is expected that normal animals form an attentional set for the stimulus dimension rewarded in earlier phases of training and testing, resulting in increased number of trials needed to reach criterion on the EDS. Following testing on the EDS, animals performed a final reversal (REV4). Relevant dimensions and rewarded stimuli were counterbalanced across groups.

Data Analysis

Trials to Criterion (TTC, 8 correct in 10 consecutive trials) was the main variable of interest and was primarily analyzed by univariate analysis of variance (ANOVA) or repeated measures ANOVA (rANOVA). Genotype (WT and Fmr1 KO) was the between subject independent variable for all analyses. The control variables (SD TTC, CD TTC, and initial reversal TTC) and probe trials (Percent Correct) were analyzed by Univariate ANOVA. The IDS problems were analyzed by rANOVA with Problem (1, 2, or 3) and Condition (discrimination or reversal) as the within-subject independent variables. Performance on the EDS and the final reversal were analyzed by Univariate ANOVA. Because Fmr1 KO mice demonstrate hyperactivity, we also analyzed Latency to Choose in order to clarify whether deficits were due to impulsivity/hyperactivity.

Because the TTC variable exhibited a skewed distribution, we used nonparametric approaches to test differences in the ability to form an attentional set. By convention, a significant increase in trials to criterion when a rule is changed is considered indication that an attentional set had been formed. For each group, we used the Wilcoxon Signed Rank Test to determine whether there was a significant increase in TTC between the mean IDS and the EDS. We also tested the effect size for each group using the r equivalent (Rosenthal & Rubin, 2003) and Cohen's d (Rosnow, Rosenthal, & Rubin, 2000). The r equivalent is a measure of effect size that is useful for nonparametric tests and for repeated measures tests. Cohen's d is a standard test for effect size and also can be corrected for dependent samples. In addition, we calculated the variable, Shift Effect, by subtracting the mean TTC for the IDS problems from the TTC for the EDS. Group differences in Shift Effect were analyzed by the Wilcoxon Ranked Sums Test with Genotype (WT and Fmr1 KO) as the between subject independent variable.

Data were analyzed using SPSS (V17, SPSS, Inc.) or SAS (V. 9.1.3, Sas Institute, Inc.) with a significance level of p<0.05.

Results

WT and Fmr1 KO mice were not different in acquisition of the training discriminations. ANOVA of TTC confirmed no effects of Genotype for SD (WT, 8.1±0.1; Fmr1 KO, 8.3±0.2; p>0.28), CD (WT, 8.0±0; Fmr1 KO, 8.3±0.2; p<0.17), or the initial reversal (WT, 10.0±0.4; Fmr1 KO, 9.6±0.4; p<0.45). Thus, both groups were able to learn and perform the basic elements of the task equally well, and there was no indication that Fmr1 KO mice learned the initial discriminations differently from WT mice.

Both groups of mice exhibited good performance on probe trials, indicating that odor cues were not responsible for accurate performance in the task. Each mouse completed 12 probe trials with the exception of one WT mouse that omitted two probe trials and one Fmr1 KO mouse that omitted three probe trials. Probe trial accuracy did not differ between WT and Fmr1 KO mice (91.5±2.4 vs. 87.0±2.8, p>0.24).

During testing, Fmr1 KO mice were impaired relative to WT mice (Figure 1), as indicated by significantly higher TTC across IDSs and reversals, F(1,16)=4.67, p<0.046. Reversals were more difficult for both groups of mice as confirmed by a significant effect of Condition, F(1,16)=15.29, p<0.001. There was no main effect of Problem (p>0.96) and no interaction of Genotype with Problem (p>0.87) or Condition (p>0.37).

Figure 1.

Figure 1

Performance of WT and Fmr1 KO mice during IDS, EDS, and reversal trials. TTC was 8 correct out of 10 consecutive trials. Three intradimensional shifts (IDS) and reversals (REV) were followed by the single EDS assessment and final REV. Non-parametric analyses indicated that there was no difference between WT and Fmr1 KO mice on the IDS problems, but WT mice showed the expected increase in TTC between the IDS and EDS discriminations. Importantly, Fmr1 KO mice failed to show this effect. Data are means ± standard error.

As shown in Figure 1, WT mice required a greater number of trials to reach criterion in the EDS as compared to the IDS problems. This pattern is consistent with formation of an attentional set during the three IDS and Reversal problems. In contrast, Fmr1 KO mice exhibited similar TTC for mean IDS and the EDS, suggesting the lack of attentional set formation to the original dimension. To determine whether the two groups differed on the measure of increased TTC for the EDS, for each mouse we calculated a Shift Effect (TTC for the EDS minus mean IDS). Seven of 9 WT mice exhibited a positive Shift Effect as compared to 2 of 9 Fmr1 KO mice. Moreover, Fmr1 KO mice were significantly less likely to exhibit a Shift Effect, as confirmed by a Wilcoxon rank-sum test, (W = 64, p <0.032, requivalent = 0.42, d=0.99). An requivalent of 0.42 and Cohen's d of 0.99 are both considered to indicate a large effect size. The Wilcoxon Signed Rank Test indicated that the increase in TTC between the mean IDS and the EDS was significantly different for the WT mice (S=17, p< 0.0156, requivalent = 0.75, d = 2.37). The requivalent indicates a large effect size, and the Cohen's d is considered quite large. In contrast, the difference between the final IDS and the EDS was not significant for the Fmr1 KO mice (p>0.719).

Latency to choose did not differ by Problem or Genotype (p>0.22) for the IDSs and reversals. There was, however, a trend toward faster latencies for the Fmr1 KO mice for the EDS and subsequent reversal, compared to the WT mice, F(1,16)=4.162, p<0.058. Shorter latencies of the Fmr1 KO mice when the relevant stimuli represent a new perceptual dimension further supports the interpretation that Fmr1 KO mice had not formed an attentional set.

Discussion

The present study examined attentional set formation in a mouse model of FXS. Fmr1 KO and WT mice learned the initial and complex discriminations equally well, indicating they were able to acquire the basic components of the task and to process each of three perceptual dimensions. Our evidence suggests that WT mice formed an attentional set as they exhibited the expected increase in TTC following a shift of the relevant perceptual dimension. In comparison, Fmr1 KO mice exhibited no difference in TTC between the mean IDS and the EDS. This result is consistent with an impairment in attentional set formation, and is the first demonstration of such deficits in Fmr1 KO mice.

Previous studies failed to reveal expected effects of attentional set formation in WT mice (Bissonette et al., 2008; Brigman, et al., 2005; Colacicco, et al., 2002). In these studies, tasks involved only two perceptual dimensions, and there were fewer IDS problems prior to the EDS. Thus, subjects may not have formed attentional sets when learning the original discrimination. One group reported a decrease in performance during EDS, but the shift occurred in both perceptual dimension (odor or texture) and presentation mode (Young, Powell, Geyer, Jeste, & Risbrough, 2010). Odor was presented as scented bedding in a ceramic container, but texture was presented on the platform on which the container was positioned. This effect is more similar to a task shift, as opposed to a shift in a perceptual dimension. Another group reported a set-shifting effect when a third perceptual dimension was introduced in the EDS (2006). Thus, subjects were required to integrate a completely novel dimension into their perceptual set, while inhibiting attention to familiar dimensions and shifting to the novel dimension. This could bias performance in mouse strains that are hyper-reactive to unfamiliar conditions, such as Fmr1 KO mice (Chen & Toth, 2001). In our task, three perceptual dimensions were presented throughout testing, one relevant, one irrelevant and varying, and one not varying. In addition, the order of presentation of perceptual dimensions and the particular stimuli used were counterbalanced. Finally, we introduced multiple IDSs and reversals to encourage formation of attentional set. This paradigm resulted in the expected shift effect in the WT mice and was also amenable for use with Fmr1 KO mice.

In the present study, Fmr1 KO mice showed deficits in discrimination and reversal learning and in the formation of an attentional set. FXS individuals also have deficits in discrimination and reversal learning (Kogan et al., 2004). With regard to attentional set formation, the comparison is less straightforward. FXS individuals exhibit deficits in executive function, but the severity of impairment varies depending on the task. For example, working memory deficits tend to emerge when the attentional load exceeds attentional resources (Munir, et al., 2000a). Patients with FXS have difficulty shifting from one rule to another in tasks, for example in the WCST on which they make significantly more perseverative errors than control subjects (K. M. Cornish, et al., 2001; Mazzocco, Pennington, & Hagerman, 1993; Mostofsky, et al., 1998). Set-shifting deficits were also demonstrated on a subtest of the Contingency Naming Test (Hooper, et al., 2008). In the WCST and the CNT, FXS individuals form attentional sets as demonstrated by increased perseverative errors when the rule shifts, consistent with formation of an attentional set and difficulty in shifting attention. This contrasts with our results in the Fmr1 KO. The materials in the WCST and CNT (shape, color, number) may be sufficiently simple to support the formation of an attentional set, as the rules are all within the same modality. Moreover, FXS individuals exhibit relatively intact visual-perceptual abilities in terms of form and color (Kogan, et al., 2004). To our knowledge, there has been no parametric examination of the role of complexity or perceptual modality in attentional set formation in FXS.

In rodent attentional set-shifting tasks, the perceptual dimensions differ in modality, an identified difference from primate models of attentional set formation (reviewed in (Robbins & Arnsten, 2009)). Thus, one possibility is that the requirement to shift modalities exceeded the attentional resources of the Fmr1 KO mice. We suggest this is the basis of the impairment in attentional set formation. Alternatively, it is possible that, despite impairment in learning the discriminations, the Fmr1 KO were facilitated in shifting to the new dimension. If that were the case, however, facilitated reversal learning would also be expected, which was not the case. We also observed a trend of the Fmr1 KO mice to demonstrate shorter latencies to choose at the EDS and the final reversal as compared to WT mice. We assert this provides further evidence for impaired set formation. In addition, although not conclusive, the trend suggests increased impulsivity, another prominent feature of FXS.

Our findings are consistent with impaired executive function and inhibitory control in a mouse model of FXS, confirming the utility of this mouse model for investigation of the neuroanatomical and neurophysiological basis for FXS deficits in executive function.

Acknowledgments

This research was supported by an NIMH R01 (MH60284) to RDB and summer undergraduate fellowships to KC were supported by an NSF Award (IOB-0522220) to RDB. We would like to thank Kara Agster for her help in setting up the task and Kevin Bath for his very helpful comments on the manuscript.

Footnotes

Publisher's Disclaimer: The following manuscript is the final accepted manuscript. It has not been subjected to the final copyediting, fact-checking, and proofreading required for formal publication. It is not the definitive, publisher-authenticated version. The American Psychological Association and its Council of Editors disclaim any responsibility or liabilities for errors or omissions of this manuscript version, any version derived from this manuscript by NIH, or other third parties. The published version is available at www.apa.org/pubs/journals/bne

References

  1. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat Genet. 1993;4(2):147–153. doi: 10.1038/ng0693-147. [DOI] [PubMed] [Google Scholar]
  2. Birrell JM, Brown VJ. Medial frontal cortex mediates perceptual attentional set shifting in the rat. J Neurosci. 2000;20(11):4320–4324. doi: 10.1523/JNEUROSCI.20-11-04320.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bissonette GB, Martins GJ, Franz TM, Harper ES, Schoenbaum G, Powell EM. Double dissociation of the effects of medial and orbital prefrontal cortical lesions on attentional and affective shifts in mice. J Neurosci. 2008;28(44):11124–11130. doi: 10.1523/JNEUROSCI.2820-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Brigman JL, Bussey TJ, Saksida LM, Rothblat LA. Discrimination of multidimensional visual stimuli by mice: intra- and extradimensional shifts. Behav Neurosci. 2005;119(3):839–842. doi: 10.1037/0735-7044.119.3.839. [DOI] [PubMed] [Google Scholar]
  5. Chen L, Toth M. Fragile X mice develop sensory hyperreactivity to auditory stimuli. Neuroscience. 2001;103(4):1043–1050. doi: 10.1016/s0306-4522(01)00036-7. [DOI] [PubMed] [Google Scholar]
  6. Colacicco G, Welzl H, Lipp HP, Wurbel H. Attentional set-shifting in mice: modification of a rat paradigm, and evidence for strain-dependent variation. Behav Brain Res. 2002;132(1):95–102. doi: 10.1016/s0166-4328(01)00391-6. [DOI] [PubMed] [Google Scholar]
  7. Comery TA, Harris JB, Willems PJ, Oostra BA, Irwin SA, Weiler IJ, et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc Natl Acad Sci U S A. 1997;94(10):5401–5404. doi: 10.1073/pnas.94.10.5401. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Consortium, D.-B. F. X. Fmr1 knockout mice: a model to study fragile X mental retardation. The Dutch-Belgian Fragile X Consortium. Cell. 1994;78(1):23–33. [PubMed] [Google Scholar]
  9. Cornish K, Burack JA, Rahman A, Munir F, Russo N, Grant C. Theory of mind deficits in children with fragile X syndrome. J Intellect Disabil Res. 2005;49(Pt 5):372–378. doi: 10.1111/j.1365-2788.2005.00678.x. [DOI] [PubMed] [Google Scholar]
  10. Cornish K, Scerif G, Karmiloff-Smith A. Tracing syndrome-specific trajectories of attention across the lifespan. Cortex. 2007;43(6):672–685. doi: 10.1016/s0010-9452(08)70497-0. [DOI] [PubMed] [Google Scholar]
  11. Cornish K, Sudhalter V, Turk J. Attention and language in fragile X. Ment Retard Dev Disabil Res Rev. 2004;10(1):11–16. doi: 10.1002/mrdd.20003. [DOI] [PubMed] [Google Scholar]
  12. Cornish KM, Munir F, Cross G. Differential impact of the FMR-1 full mutation on memory and attention functioning : a neuropsychological perspective. J Cogn Neurosci. 2001;13(1):144–150. doi: 10.1162/089892901564126. [DOI] [PubMed] [Google Scholar]
  13. D'Hooge R, Nagels G, Franck F, Bakker CE, Reyniers E, Storm K, et al. Mildly impaired water maze performance in male Fmr1 knockout mice. Neuroscience. 1997;76(2):367–376. doi: 10.1016/s0306-4522(96)00224-2. [DOI] [PubMed] [Google Scholar]
  14. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel JL. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet. 1993;4(4):335–340. doi: 10.1038/ng0893-335. [DOI] [PubMed] [Google Scholar]
  15. Freund LS, Reiss AL. Cognitive profiles associated with the fra(X) syndrome in males and females. Am J Med Genet. 1991;38(4):542–547. doi: 10.1002/ajmg.1320380409. [DOI] [PubMed] [Google Scholar]
  16. Garner JP, Thogerson CM, Wurbel H, Murray JD, Mench JA. Animal neuropsychology: validation of the Intra-Dimensional Extra-Dimensional set shifting task for mice. Behav Brain Res. 2006;173(1):53–61. doi: 10.1016/j.bbr.2006.06.002. [DOI] [PubMed] [Google Scholar]
  17. Gothelf D, Furfaro JA, Hoeft F, Eckert MA, Hall SS, O'Hara R, et al. Neuroanatomy of fragile X syndrome is associated with aberrant behavior and the fragile X mental retardation protein (FMRP) Ann Neurol. 2008;63(1):40–51. doi: 10.1002/ana.21243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Haas BW, Barnea-Goraly N, Lightbody AA, Patnaik SS, Hoeft F, Hazlett H, et al. Early white-matter abnormalities of the ventral frontostriatal pathway in fragile X syndrome. Dev Med Child Neurol. 2009;51(8):593–599. doi: 10.1111/j.1469-8749.2009.03295.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hagerman RJ, Amiri K, Cronister A. Fragile X checklist. Am J Med Genet. 1991;38(2-3):283–287. doi: 10.1002/ajmg.1320380223. [DOI] [PubMed] [Google Scholar]
  20. Hessl D, Rivera SM, Reiss AL. The neuroanatomy and neuroendocrinology of fragile X syndrome. Ment Retard Dev Disabil Res Rev. 2004;10(1):17–24. doi: 10.1002/mrdd.20004. [DOI] [PubMed] [Google Scholar]
  21. Hinds HL, Ashley CT, Sutcliffe JS, Nelson DL, Warren ST, Housman DE, et al. Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nat Genet. 1993;3(1):36–43. doi: 10.1038/ng0193-36. [DOI] [PubMed] [Google Scholar]
  22. Hoeft F, Carter JC, Lightbody AA, Cody Hazlett H, Piven J, Reiss AL. Region-specific alterations in brain development in one- to three-year-old boys with fragile X syndrome. Proc Natl Acad Sci U S A. 2010;107(20):9335–9339. doi: 10.1073/pnas.1002762107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hoeft F, Hernandez A, Parthasarathy S, Watson CL, Hall SS, Reiss AL. Fronto-striatal dysfunction and potential compensatory mechanisms in male adolescents with fragile X syndrome. Hum Brain Mapp. 2007;28(6):543–554. doi: 10.1002/hbm.20406. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Hoeft F, Lightbody AA, Hazlett HC, Patnaik S, Piven J, Reiss AL. Morphometric spatial patterns differentiating boys with fragile X syndrome, typically developing boys, and developmentally delayed boys aged 1 to 3 years. Arch Gen Psychiatry. 2008;65(9):1087–1097. doi: 10.1001/archpsyc.65.9.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Hooper SR, Hatton D, Sideris J, Sullivan K, Hammer J, Schaaf J, et al. Executive functions in young males with fragile X syndrome in comparison to mental age-matched controls: baseline findings from a longitudinal study. Neuropsychology. 2008;22(1):36–47. doi: 10.1037/0894-4105.22.1.36. [DOI] [PubMed] [Google Scholar]
  26. Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP, et al. Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet. 2001;98(2):161–167. doi: 10.1002/1096-8628(20010115)98:2<161::aid-ajmg1025>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  27. Kau AS, Reider EE, Payne L, Meyer WA, Freund L. Early behavior signs of psychiatric phenotypes in fragile X syndrome. Am J Ment Retard. 2000;105(4):286–299. doi: 10.1352/0895-8017(2000)105<0286:EBSOPP>2.0.CO;2. [DOI] [PubMed] [Google Scholar]
  28. Kogan CS, Boutet I, Cornish K, Zangenehpour S, Mullen KT, Holden JJ, et al. Differential impact of the FMR1 gene on visual processing in fragile X syndrome. Brain. 2004;127(Pt 3):591–601. doi: 10.1093/brain/awh069. [DOI] [PubMed] [Google Scholar]
  29. Kooy RF. Of mice and the fragile X syndrome. Trends Genet. 2003;19(3):148–154. doi: 10.1016/s0168-9525(03)00017-9. [DOI] [PubMed] [Google Scholar]
  30. Kwon H, Menon V, Eliez S, Warsofsky IS, White CD, Dyer-Friedman J, et al. Functional neuroanatomy of visuospatial working memory in fragile X syndrome: relation to behavioral and molecular measures. Am J Psychiatry. 2001;158(7):1040–1051. doi: 10.1176/appi.ajp.158.7.1040. [DOI] [PubMed] [Google Scholar]
  31. Lanfranchi S, Cornoldi C, Drigo S, Vianello R. Working memory in individuals with fragile X syndrome. Child Neuropsychol. 2009;15(2):105–119. doi: 10.1080/09297040802112564. [DOI] [PubMed] [Google Scholar]
  32. Levitas A. Neuropsychiatric Aspects of Fragile X Syndrome. Semin Clin Neuropsychiatry. 1996;1(2):154–167. doi: 10.1053/SCNP00100154. [DOI] [PubMed] [Google Scholar]
  33. Lie CH, Specht K, Marshall JC, Fink GR. Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test. Neuroimage. 2006;30(3):1038–1049. doi: 10.1016/j.neuroimage.2005.10.031. [DOI] [PubMed] [Google Scholar]
  34. Lightbody AA, Reiss AL. Gene, brain, and behavior relationships in fragile X syndrome: evidence from neuroimaging studies. Dev Disabil Res Rev. 2009;15(4):343–352. doi: 10.1002/ddrr.77. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Mazzocco MM, Pennington BF, Hagerman RJ. The neurocognitive phenotype of female carriers of fragile X: additional evidence for specificity. J Dev Behav Pediatr. 1993;14(5):328–335. [PubMed] [Google Scholar]
  36. McKinney BC, Grossman AW, Elisseou NM, Greenough WT. Dendritic spine abnormalities in the occipital cortex of C57BL/6 Fmr1 knockout mice. Am J Med Genet B Neuropsychiatr Genet. 2005;136B(1):98–102. doi: 10.1002/ajmg.b.30183. [DOI] [PubMed] [Google Scholar]
  37. Menon V, Kwon H, Eliez S, Taylor AK, Reiss AL. Functional brain activation during cognition is related to FMR1 gene expression. Brain Res. 2000;877(2):367–370. doi: 10.1016/s0006-8993(00)02617-2. [DOI] [PubMed] [Google Scholar]
  38. Menon V, Leroux J, White CD, Reiss AL. Frontostriatal deficits in fragile X syndrome: relation to FMR1 gene expression. Proc Natl Acad Sci U S A. 2004;101(10):3615–3620. doi: 10.1073/pnas.0304544101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Monchi O, Petrides M, Petre V, Worsley K, Dagher A. Wisconsin Card Sorting revisited: distinct neural circuits participating in different stages of the task identified by event-related functional magnetic resonance imaging. J Neurosci. 2001;21(19):7733–7741. doi: 10.1523/JNEUROSCI.21-19-07733.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Moon J, Beaudin AE, Verosky S, Driscoll LL, Weiskopf M, Levitsky DA, et al. Attentional dysfunction, impulsivity, and resistance to change in a mouse model of fragile X syndrome. Behav Neurosci. 2006;120(6):1367–1379. doi: 10.1037/0735-7044.120.6.1367. [DOI] [PubMed] [Google Scholar]
  41. Mostofsky SH, Mazzocco MM, Aakalu G, Warsofsky IS, Denckla MB, Reiss AL. Decreased cerebellar posterior vermis size in fragile X syndrome: correlation with neurocognitive performance. Neurology. 1998;50(1):121–130. doi: 10.1212/wnl.50.1.121. [DOI] [PubMed] [Google Scholar]
  42. Munir F, Cornish KM, Wilding J. Nature of the working memory deficit in fragile-X syndrome. Brain Cogn. 2000a;44(3):387–401. doi: 10.1006/brcg.1999.1200. [DOI] [PubMed] [Google Scholar]
  43. Munir F, Cornish KM, Wilding J. A neuropsychological profile of attention deficits in young males with fragile X syndrome. Neuropsychologia. 2000b;38(9):1261–1270. doi: 10.1016/s0028-3932(00)00036-1. [DOI] [PubMed] [Google Scholar]
  44. Nimchinsky EA, Oberlander AM, Svoboda K. Abnormal development of dendritic spines in FMR1 knock-out mice. J Neurosci. 2001;21(14):5139–5146. doi: 10.1523/JNEUROSCI.21-14-05139.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Ornstein PA, Schaaf JM, Hooper SR, Hatton DD, Mirrett P, Bailey DB., Jr Memory skills of boys with fragile X syndrome. Am J Ment Retard. 2008;113(6):453–465. doi: 10.1352/2008.113:453-465. [DOI] [PubMed] [Google Scholar]
  46. Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST. Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience. 1999;94(1):185–192. doi: 10.1016/s0306-4522(99)00285-7. [DOI] [PubMed] [Google Scholar]
  47. Pieretti M, Zhang FP, Fu YH, Warren ST, Oostra BA, Caskey CT, et al. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell. 1991;66(4):817–822. doi: 10.1016/0092-8674(91)90125-i. [DOI] [PubMed] [Google Scholar]
  48. Qin M, Kang J, Smith CB. Increased rates of cerebral glucose metabolism in a mouse model of fragile X mental retardation. Proc Natl Acad Sci U S A. 2002;99(24):15758–15763. doi: 10.1073/pnas.242377399. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Reiss AL, Abrams MT, Greenlaw R, Freund L, Denckla MB. Neurodevelopmental effects of the FMR-1 full mutation in humans. Nat Med. 1995;1(2):159–167. doi: 10.1038/nm0295-159. [DOI] [PubMed] [Google Scholar]
  50. Reiss AL, Aylward E, Freund LS, Joshi PK, Bryan RN. Neuroanatomy of fragile X syndrome: the posterior fossa. Ann Neurol. 1991;29(1):26–32. doi: 10.1002/ana.410290107. [DOI] [PubMed] [Google Scholar]
  51. Reiss AL, Freund L. Fragile X syndrome, DSM-III-R, and autism. J Am Acad Child Adolesc Psychiatry. 1990;29(6):885–891. doi: 10.1097/00004583-199011000-00007. [DOI] [PubMed] [Google Scholar]
  52. Rivera SM, Menon V, White CD, Glaser B, Reiss AL. Functional brain activation during arithmetic processing in females with fragile X Syndrome is related to FMR1 protein expression. Hum Brain Mapp. 2002;16(4):206–218. doi: 10.1002/hbm.10048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Robbins TW, Arnsten AF. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation. Annu Rev Neurosci. 2009;32:267–287. doi: 10.1146/annurev.neuro.051508.135535. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Rosenthal R, Rubin DB. r equivalent: A simple effect size indicator. Psychol Methods. 2003;8(4):492–496. doi: 10.1037/1082-989X.8.4.492. [DOI] [PubMed] [Google Scholar]
  55. Rosnow RL, Rosenthal R, Rubin DB. Contrasts and correlations in effect-size estimation. Psychol Sci. 2000;11(6):446–453. doi: 10.1111/1467-9280.00287. [DOI] [PubMed] [Google Scholar]
  56. Scerif G, Cornish K, Wilding J, Driver J, Karmiloff-Smith A. Delineation of early attentional control difficulties in fragile X syndrome: focus on neurocomputational changes. Neuropsychologia. 2007;45(8):1889–1898. doi: 10.1016/j.neuropsychologia.2006.12.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Silva AJ, Simpson EM, Takahashi JS, Lipp HP, Nakanishi S, Wehner JM, et al. Mutant mice and neuroscience: Recommendations concerning genetic control. Neuron. 1997;19:755–759. doi: 10.1016/s0896-6273(00)80958-7. [DOI] [PubMed] [Google Scholar]
  58. Tamm L, Menon V, Johnston CK, Hessl DR, Reiss AL. fMRI study of cognitive interference processing in females with fragile X syndrome. J Cogn Neurosci. 2002;14(2):160–171. doi: 10.1162/089892902317236812. [DOI] [PubMed] [Google Scholar]
  59. Turner G, Webb T, Wake S, Robinson H. Prevalence of fragile X syndrome. Am J Med Genet. 1996;64(1):196–197. doi: 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  60. Verheij C, Bakker CE, de Graaff E, Keulemans J, Willemsen R, Verkerk AJ, et al. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 1993;363(6431):722–724. doi: 10.1038/363722a0. [DOI] [PubMed] [Google Scholar]
  61. Wilding J, Cornish K, Munir F. Further delineation of the executive deficit in males with fragile-X syndrome. Neuropsychologia. 2002;40(8):1343–1349. doi: 10.1016/s0028-3932(01)00212-3. [DOI] [PubMed] [Google Scholar]
  62. Young JW, Powell SB, Geyer MA, Jeste DV, Risbrough VB. The mouse attentional-set-shifting task: a method for assaying successful cognitive aging? Cogn Affect Behav Neurosci. 2010;10(2):243–251. doi: 10.3758/CABN.10.2.243. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Zhao MG, Toyoda H, Ko SW, Ding HK, Wu LJ, Zhuo M. Deficits in trace fear memory and long-term potentiation in a mouse model for fragile X syndrome. J Neurosci. 2005;25(32):7385–7392. doi: 10.1523/JNEUROSCI.1520-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES